NCT06303648View on ClinicalTrials.gov

A Single, Ascending Dose Evaluation of the Safety, Pharmacokinetics of Methylone in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

March 20, 2024

Primary Completion Date

July 13, 2025

Study Completion Date

July 13, 2025

Conditions
Post Traumatic Stress Disorder
Interventions
DRUG

Methylone

Oral dose of methylone

DRUG

Placebo

Placebo to match methylone

Trial Locations (1)

5000

CMAX Clinical Research, Adelaide

Sponsors
All Listed Sponsors
lead

Transcend Therapeutics

INDUSTRY

NCT06303648 - A Single, Ascending Dose Evaluation of the Safety, Pharmacokinetics of Methylone in Healthy Subjects | Biotech Hunter | Biotech Hunter